MCKENNA WILKERSON: Open Payments
NPI 1649012360 · STAR CITY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 39 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $237 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $160 |
| Lundbeck LLC | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $27 |
| PFIZER INC. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: CAPLYTA, QULIPTA, REXULTI, VRAYLAR, TRELEGY ELLIPTA, Auvelity, Kerendia, FARXIGA.
Industry payments across AR — which companies pay providers there.
